QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer 期刊论文 THORACIC CANCER, 2019, 卷号: 10, 期号: 4 作者:  Chen, Ying;  Li, Guangjian;  Lei, Yujie;  Yang, Kaiyun;  Niu, Huatao 收藏  |  浏览/下载：23/0  |  提交时间：2019/12/04 Cancer susceptibility  coal combustion  lung cancer family history  non-small cell lung cancer  occupational exposure   Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications 期刊论文 FRONTIERS IN ENDOCRINOLOGY, 2019, 卷号: 10 作者:  Gao, Rui;  Jia, Xi;  Liang, Yiqian;  Fan, Kun;  Wang, Xiaoxiao 收藏  |  浏览/下载：34/0  |  提交时间：2019/11/19 131I therapy  risk of recurrence  papillary thyroid micro carcinoma  prognostic factors  total thyroidectomy   A Novel Height-Adjustable Nano-Hydroxyapatite/Polyamide-66 Vertebral Body for Reconstruction of Thoracolumbar Structural Stability After Spinal Tumor Resection 期刊论文 WORLD NEUROSURGERY, 2019, 卷号: 122 作者:  Chen, Guanghui;  Yin, Mengchen;  Liu, Weibo;  Xin, Baoquan;  Bai, Guangjian 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/06 Deformity  Endplate geometry  Nano-hydroxyapatite/polyamide-66  Reconstruction  Spinal tumor  Vertebral body   Treatment duration as a surrogate endpoint to evaluate the efficacy of crizotinib in sequential therapy for patients with advanced ALK-positive non-small cell lung cancer: A retrospective, real-world study 期刊论文 2019, 卷号: 8, 期号: 13, 页码: 5823-5830 作者:  Yang Guangjian;  Ma Di;  Xu Haiyan;  Yang Lu;  Li Junling 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 anaplastic lymphoma kinase inhibitor  crizotinib  crizotinib continuation beyond progressive disease  non-small cell lung cancer  treatment duration   Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-small-cell lung cancer after crizotinib treatment 期刊论文 2019, 卷号: 31, 期号: 2, 页码: 349-356 作者:  Xu, Haiyan;  Ma, Di;  Yang, Guangjian;  Li, Junling;  Hao, Xuezhi 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03 ALK  crizotinib  non-small-cell lung cancer  resistance  sequential therapy   Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK-rearranged non-small-cell lung cancer 期刊论文 2019, 卷号: 8, 期号: 4, 页码: 1551-1557 作者:  Song, Peng;  Zhang, Fanshuang;  Li, Yan;  Yang, Guangjian;  Li, Wenbin 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 ALK  crizotinib  non-small-cell lung cancer  survival  TP53   Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance 期刊论文 2019, 卷号: 10, 期号: 5, 页码: 1096-1102 作者:  Xu, Haiyan;  Yang, Guangjian;  Yang, Lu;  Yang, Yaning;  Ma, Di 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 ALK  crizotinib  non-small cell lung cancer  prognosis  resistance   Genomic Mechanisms of Physiological and Morphological Adaptations of Limestone Langurs to Karst Habitats 期刊论文 Molecular Biology and Evolution, 2019 作者:  Zhijin Liu;  Liye Zhang;  Zhongze Yan;  Zhijie Ren;  Fengming Han 收藏  |  浏览/下载：7/0  |  提交时间：2020/11/17